Posted: Nov. 12, 2020
The Horseracing Integrity and Safety Authority’s standing advisory committees and the United States Anti-Doping Agency have released initial drafts of proposed rules for review and comment.
As prescribed by the Horseracing Integrity and Safety Act of 2020, USADA has led the drafting process for the Anti-Doping and Medication Control Program. Three of the six documents pertaining to the Anti-Doping and Medication Control Program, including the proposed equine protocol, prohibited list, and definitions, have been posted for public comment. The remaining documents, which include equine arbitration procedures, testing and investigation standards, and standards for laboratories and accreditation will be published over the next two weeks.
Rules and regulations for the Racetrack Safety Program, which is separate from USADA and made up of expanded veterinary exam protocols, enhanced racing and training requirements, minimum standards for surface maintenance and testing, and uniform reporting requirements have also been posted for public review.
USADA and the advisory committees will review and incorporate relevant public feedback on the recommendations and submit them to the HISA Board of Directors for approval. Following the board approval process, the authority will present its final proposed rules to the Federal Trade
Commission in early December. That will initiate a formal notice and comment rule-making process during which stakeholders and the general public may once again weigh in by submitting comments for a 60-day period, after which the FTC will publish final regulations.
(Photo by Jim McCue)